ShockWave Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Total Interest Expense	0.49	0.53	1.09	0.71	-	0
Net Interest Income	-0.49	-0.53	-1.09	-0.71	-	-0
Other Revenue	13.12	15.24	17.56	9.48	7.01	8.04
Revenue Before Loan Losses	12.63	14.71	16.47	8.77	7.01	8.04
Provision for Loan Losses	-1.32	-1.39	0.29	0.51	0	0.01
Revenue	13.96	16.1	16.18	8.27	7	8.02
Revenue Growth (YoY)	-16.29%	-0.46%	95.68%	18.04%	-12.69%	-
Salaries & Employee Benefits	6.85	7.78	10.33	6.7	2.14	1.73
Cost of Services Provided	7.35	6.79	8.76	4.24	1.58	1.18
Total Operating Expenses	14.19	14.58	19.1	10.93	3.72	2.91
Operating Income	-0.24	1.52	-2.92	-2.67	3.29	5.12
EBT Excluding Unusual Items	2.43	4.33	-4.77	-44.05	3.29	5.12
Impairment of Goodwill	-6.06	-6.06	-13.21	-	-	-
Other Unusual Items	0.34	0.36	4.57	-0.1	-	-
Pretax Income	-6.38	-4.46	-19.11	-44.38	3.29	5.12
Income Tax Expense	44.3	43.86	-1.83	-9.25	-	-
Net Income	-50.68	-48.32	-17.28	-35.13	3.29	5.12
Net Income to Common	-50.68	-48.32	-17.28	-35.13	3.29	5.12
Net Income Growth	-	-	-	-	-35.74%	-
Shares Outstanding (Basic)	3	3	2	1	-	-
Shares Outstanding (Diluted)	3	3	2	1	-	-
Shares Change (YoY)	11.26%	30.26%	124.21%	-	-	-
EPS (Basic)	-18.24	-17.43	-8.12	-37.00	-	-
EPS (Diluted)	-18.24	-17.43	-8.12	-37.00	-	-
Free Cash Flow	-2.19	0.43	-1.04	1.68	2.94	4.95
Free Cash Flow Per Share	-0.79	0.15	-0.49	1.77	-	-
Operating Margin	-1.70%	9.46%	-18.04%	-32.26%	46.93%	63.76%
Profit Margin	-363.15%	-300.08%	-106.81%	-424.90%	46.93%	63.76%
Free Cash Flow Margin	-15.66%	2.67%	-6.43%	20.32%	41.98%	61.69%

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.

SEC Filings: 10-K · 10-Q